Canadian importers have been asked to quarantine health products made at
IPCA Laboratories' Pithampur facility in Madhya Pradesh and Dr Reddy's
Laboratories' Srikakulam plant in Andhra Pradesh due to data integrity
The order was issued by Health Canada, the North American country's food and
In response to the alert, which was issued on December 23, Dr Reddy's says
the company is currently working with the food and drug regulator to resolve
"At Health Canada's request, Canadian importers have agreed to quarantine
health products due to data integrity concerns from Dr Reddy's Laboratories in
Srikakulam and IPCA Laboratories in Pithampur. Health Canada has taken this
action as an interim precautionary measure to help mitigate any potential
risk," said a statement from Health Canada.
"All the active pharmaceutical ingredients (APIs) manufactured at the
Srikakulam facility have voluntarily been placed under quarantine. However, the
impacts of the Health Canada action on operations and financials are yet to be
assessed," a DRL spokesperson said, adding there was no production loss yet.
"Health Canada is likely to rely on USFDA's inspection and their reports to
take future course of action. Both DRL and IPCA Labs do not derive significant
revenues from these facilities. Hence, we don't think the development would
have an impact on the companies," said, Sarabjit Kour Nangra,
vice-president - research, Angel Broking.
"No products manufactured at these sites for the Canadian market
have been determined to be medically necessary. Products will
continue to be assessed for medical necessity," Sarabjit Kour